Our study on Chinese NSCLC patients found 20 patients (0.22 %) with BRCA1 and 66 patients (0.73 %) with BRCA2 pathogenic germline mutations, representing a comprehensive report on the incidence of BRCA1/2 germline mutations in Chinese NSCLC. The gene discussed is BRCA1; the disease is non-small cell lung carcinoma.